Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE’S ADVISES ON THE SALE OF LEOS LEKLAND
Mandate

VINGE’S ADVISES ON THE SALE OF LEOS LEKLAND

October 30, 2014

Vinge has advised KFI Kapital AB, a wholly owned subsidiary within the KF group, as well as other sellers in connection with the sale of Leos Lekland to Litorina. Leos Lekland was founded in Luleå in 2006 and is currently the Nordic region’s leading chain of children’s activity and adventure centres with 22 owned facilities and an anticipated turnover in 2014 of approximately SEK 250 million.

Vinge’s team consisted of responsible partner Johan Winnerblad together with, among others, associates Joacim Rydergård, Alex Miler and Filip Öhrner as well as paralegal Sara Andersson.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026